Long-term exposure to nicotine causes long-lasting changes in behavior which reflect in part changes in the abundance and activity of nicotinic acetylcholine receptors. The molecular mechanisms underlying this adaptation to nicotine are not well understood in any organism. To address these questions, we have been investigating nicotine adaptation in C. elegans . Acute treatment with nicotinic agonists such as nicotine and levamisole leads to body muscle hypercontraction and paralysis, increased pharyngeal pumping, and stimulation of egg laying under conditions inhibitory for egg laying. Long-term treatment with nicotine confers recovery from these effects, a process we have termed adaptation: worms regain movement, decrease their rate of pharyngeal pumping, and fail to be stimulated to lay eggs under inhibitory conditions. At least some of these behavioral changes (in particular those related to egg-laying) occur at least in part through downregulation of nicotinic receptor abundance. To identify molecules involved in the regulation of nicotinic receptor abundance or activity, we have conducted genetic screens for mutants that are hypersensitive or fail to adapt to nicotine. Among the genes identified in these screens is a new gene,
nic-1 .
nic-1 mutants are strongly nicotine hypersensitive: they undergo paralysis and are stimulated to lay eggs at doses of nicotine three-fold lower than wild type. In addition, these mutants exhibited phenotypes that support
nic-1 's possible role in the regulation of cholinergic neurotransmission. For example,
nic-1 animals were hyperactive for egg-laying and showed an egg-laying pattern reminiscent of wild-type animals treated with cholinergic agonists. Moreover, they displayed abnormalities in locomotion and male mating, two behaviors known to be controlled by cholinergic motor neurons. Experiments with UNC-29::GFP chimeras indicated that
nic-1 mutants actually had reduced levels of the levamisole receptor in vulval muscles and normal levels in body muscles; thus, we believe the hypersensitivity of
nic-1 animals reflects a change in receptor activity rather than abundance. To gain more information about the effect of
nic-1 on nicotinic receptor activity, we are collaborating with Janet Richmond to obtain electrical recordings from the body muscle and egg-laying NMJs of
nic-1 animals. We have also mapped
nic-1 to an approximately a 100kb interval on LGX; thus, we are optimistic about the prospect of understanding the molecular identity of
nic-1 very soon, and hope to report our findings at the meeting.